AAIC 2025 Abstract
A probabilistic framework for the diagnostic utility of tau‐PET
By Bastiaan G J van Tol, Colin Groot, Elsmarieke van de Giessen, Show 2 more authorsRik Ossenkoppele
Computational studyBiomarkers
Abstract
Background: The tau‐PET radiotracer [18F]flortaucipir enables in vivo detection of tau pathology in Alzheimer’s Disease (AD) and has recently been FDA‐ and EMA‐approved for clinical use.
